Back

Paradigm shift in lung cancer treatment

Learning Objectives: 1. Outline the major clinical trials regarding neoadjuvant chemoimmunotherapy in treatment of lung cancer. 2. Illustrate the implication of the major clinical trials. 3. Share the different lung cancer treatment options

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.75 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

$30

Standard

Listed by the provider · thecmecenter.org

  • Conference / congress
  • Credit · Up to 0.75 credits
  • $30
  • Released
    Aug 1, 2025
  • Last day to claim credit
    Mar 9, 2028 1 year left